Related Experiment Video
Updated: Dec 1, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
[Pharmacogenomics: precision tool in routine prescription]
1Central Clinical School, Faculty of Medicine and Health, University of Sydney/Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney NSW 2050, Australia. bing.yu@sydney.edu.au.
Summary
Pharmacogenomics uses DNA analysis to personalize drug therapy, improving effectiveness and safety. This approach helps prevent ineffective treatments and reduces adverse drug reactions, especially for pediatric patients.
Area of Science:
- Genetics
- Pharmacology
- Personalized Medicine
Background:
- Pharmacogenomics analyzes genes affecting drug concentration (pharmacokinetics) and action (pharmacodynamics).
- Current drug treatment relies on a trial-observation-adjustment model, often leading to ineffective treatments and adverse drug reactions.
- Integrating genomic data is crucial for optimizing drug therapy.
Purpose of the Study:
- To highlight pharmacogenomics as an emerging tool for enhancing drug efficacy and safety.
- To emphasize the need for clinicians to integrate genomic data into clinical practice.
- To explore the potential benefits of pharmacogenomics in pediatric patient care.
Main Methods:
- DNA analysis of genes related to pharmacokinetics and pharmacodynamics.
- Integration of genomic data into clinical benefit-risk assessments.
- Development of population-specific gene panels and identification of ancestor-related alleles.
Main Results:
- Pharmacogenomics enables the selection of the right drug and dose for the right patient.
- It helps prevent ineffective treatments and reduces adverse drug reactions.
- Potential for improved drug compliance and patient-provider relationships, particularly in pediatric populations.
Conclusions:
- Clinicians must embrace pharmacogenomics advancements for improved patient outcomes.
- Active participation in clinical research is vital for developing tailored pharmacogenomic tools.
- Implementing pharmacogenomics in first-line clinical practice promises significant achievements in personalized medicine.
Related Concept Videos
01:24Dosage Regimen: Individualization
88
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
88
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
67
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
67
01:12Analysis of Population Pharmacokinetic Data
569
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
569
01:28Dosage Regimens: Designs and Approaches
150
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
150
01:29Therapeutic Drug Monitoring: Affecting Factors
95
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
95
01:20Measurement of Bioavailability: Pharmacodynamic Methods
98
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
98